Mark joined GeoVax in 2006 and currently serves as the Company’s Chief Financial Officer. Prior to joining GeoVax, he served as Chief Financial Officer for HealthWatchSystems, Inc. a privately held company in the consumer healthcare industry; Chief Financial Officer for Duska Therapeutics, Inc., a publicly held biotechnology company; Chief Financial Officer of CytRx Corporation, a publicly held biopharmaceutical company. Mr. Reynolds began his career as an auditor with Arthur Andersen & Co. He is a certified public accountant and earned a Masters of Accountancy and Bachelor Degree in Accounting, both from the University of Georgia.